RDCM insider files Form 144 for 6,670-share sale; recent 2025 dispositions listed

Rhea-AI Filing Summary

Radcom Ltd. (RDCM) filed a Form 144 notifying the proposed sale of 6,670 common shares on or about 08/19/2025 through Oppenheimer & Co. at Nasdaq, with an aggregate market value of $87,710.50. The securities were acquired on 10/15/2024 under the company's employee stock options plan and will be paid in cash upon exercise. The filing also discloses recent open-market dispositions by the same holder: 866, 201, 433 and 1,000 shares sold between 05/20/2025 and 08/14/2025, generating listed gross proceeds. The filer affirms no undisclosed material adverse information.

Positive

• Acquisition source disclosed: Securities were acquired under an employee stock options plan, indicating compensation-based origin rather than undisclosed transfers
• Broker and market identified: Sale to be executed via Oppenheimer & Co. on Nasdaq, providing transparent execution venue

Negative

• Insider selling activity: The filer previously sold 2,500 shares in 2025 and now proposes to sell 6,670 additional shares, which may be viewed negatively by some investors
• No 10b5-1 plan date provided: The filing does not state adoption of a written trading plan or instruction date, leaving the context of sales timing unspecified

Insights

Securities Analyst

TL;DR Insider plans a modest sale of 6,670 shares acquired via employee options, following several small open-market disposals earlier in 2025.

The proposed sale is funded by options exercised on 10/15/2024 and routed through a broker to Nasdaq. The disclosed aggregate value (~$87.7k) is small relative to many public-company market caps, suggesting limited standalone market impact. Recent prior sales (totaling 2,500 shares) indicate the seller has been realizing holdings periodically rather than a single large liquidation.

Corporate Governance Specialist

TL;DR Routine insider liquidity event documented; disclosure meets Rule 144 notice requirements and includes prior recent sales.

The filing contains required representations about absence of undisclosed material information and notes the securities were acquired under an employee stock option plan. From a governance perspective, periodic sales via Form 144 are common for insiders converting equity compensation to cash. The document does not disclose any trading plan adoption date or 10b5-1 details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	6670	87710.50	15915616	08/19/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	10/15/2024	Employee stock Options plan	From the Issuer			6670	08/19/2025	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Yaron Ravkaie 24 Raoul Wallenberg Street Tel Aviv L3 69179	common	05/20/2025	866	11725.64
Yaron Ravkaie 24 Raoul Wallenberg Street TEL AVIV L3 69179	Common	05/27/2025	201	2633.10
Yaron Ravkaie 24 Raoul Wallenberg Street Tel Aviv L3 69179	Common	05/29/2025	433	5823.85
Yaron Ravkaie 24 Raoul Wallenberg Street, Tel Aviv L3 69179	Common	08/14/2025	1000	13119.87

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Radcom (RDCM) Form 144 disclose about the planned sale?

The Form 144 notifies a proposed sale of 6,670 common shares on or about 08/19/2025 via Oppenheimer & Co. on Nasdaq with an aggregate market value of $87,710.50.

How and when were the shares to be sold on Radcom's Form 144 acquired?

The shares were acquired on 10/15/2024 under an employee stock options plan, with payment noted as cash upon exercise.

Has the filer sold Radcom shares recently before this Form 144?

Yes. The filing lists prior sales of 866, 201, 433, and 1,000 shares on 05/20/2025, 05/27/2025, 05/29/2025, and 08/14/2025 respectively.

Does the Form 144 indicate any undisclosed material information about Radcom?

The filer certifies by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.

Will the planned sale be executed on a public exchange?

Yes. The sale is expected to occur on Nasdaq, as stated in the filing.